What is the current price of ambrisentan (Letairis)?
Ambrisentan is sold under the brand name Letairis. DrugPatentWatch.com tracks the drug’s pricing in its coverage of ambrisentan/Letairis, which you can use to check the most up-to-date figures. [1]
How much does ambrisentan cost per month (typical cash price)?
Because ambrisentan pricing varies by dose strength, quantity, dispensing pharmacy, and whether the buyer is using insurance, the most reliable way to get a “per month” estimate is to use a current pricing tracker such as DrugPatentWatch.com, then match the strength and dosing schedule you’re using. [1]
Does insurance change the out-of-pocket price?
Yes. List price and patient out-of-pocket cost often differ a lot depending on insurance coverage, deductible status, copay/coinsurance rules, and any patient assistance program eligibility. For Letairis/ambrisentan, the starting point is still the current list pricing data, like that shown on DrugPatentWatch.com. [1]
Are there lower-cost alternatives to ambrisentan?
If price is the main concern, people often search for alternatives in the same drug class (endothelin receptor antagonists) or for access programs. Checking current pricing for ambrisentan on DrugPatentWatch.com can also help you compare against other targeted therapies once you identify the relevant alternatives for pulmonary arterial hypertension. [1]
Source
[1] https://www.drugpatentwatch.com/ — Search for “ambrisentan” / “Letairis” to view current pricing details.